A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.

People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.

Five songs providing a snapshot of how the pandemic year felt on the patient care front lines

Julian “Jay” Hinesley III, MHA, President of Vanderbilt Wilson County Hospital (VWCH), is leaving his role with Vanderbilt University Medical Center to join the Medical University of South Carolina (MUSC) as Chief Executive Officer for MUSC Health’s Florence Division in Florence, South Carolina, where he will lead three hospitals located in Florence and adjacent communities. He will depart VWCH and VUMC on April 30.

Lance Gregory wanted the message to be visible from the windows of Children's Hospital — in memory of his brother Cory

Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.

Laura Kennedy, MD, PhD, has joined Vanderbilt University Medical Center from the University of Washington School of Medicine/Fred Hutchinson Cancer Research Center in Seattle where she was acting instructor and research associate.